Get the Stockscreener App
18.79
0.48%
-0.09
After Hours:
18.79
Zimvie Inc stock is traded at $18.79, with a volume of 1.02M.
It is down -0.48% in the last 24 hours and up +100.96% over the past month.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
See More
Previous Close:
$18.88
Open:
$18.83
24h Volume:
1.02M
Relative Volume:
2.39
Market Cap:
$523.25M
Revenue:
$242.12M
Net Income/Loss:
$-351.72M
P/E Ratio:
-1.4138
EPS:
-13.29
Net Cash Flow:
$24.82M
1W Performance:
+0.32%
1M Performance:
+100.96%
6M Performance:
+35.77%
1Y Performance:
-11.12%
1-Day Range:
$18.65
$18.95
1-Week Range:
$18.65
$18.95
52-Week Range:
$8.15
$21.28
Zimvie Inc Stock (ZIMV) Company Profile
Name
Zimvie Inc
Sector
Industry
Phone
800-342-5454
Address
4555 RIVERSIDE DRIVE, PALM BEACH GARDEN
Compare ZIMV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZIMV
Zimvie Inc
|
18.79 | 532.43M | 242.12M | -351.72M | 24.82M | -13.29 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Zimvie Inc Stock (ZIMV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Apr-10-25 | Initiated | B. Riley Securities | Buy |
| Mar-13-25 | Downgrade | Needham | Buy → Hold |
| May-16-24 | Upgrade | Needham | Hold → Buy |
| Nov-16-23 | Initiated | Needham | Hold |
| Dec-21-22 | Initiated | Barclays | Underweight |
| Jun-17-22 | Initiated | JP Morgan | Neutral |
| Mar-18-22 | Initiated | Guggenheim | Neutral |
View All
Zimvie Inc Stock (ZIMV) Latest News
ZimVie (ZIMV) Q2 EPS Doubles to $0.26 - AOL.com
B.Riley downgrades ZimVie stock rating to Neutral on acquisition news By Investing.com - Investing.com South Africa
B.Riley downgrades ZimVie stock rating to Neutral on acquisition news - Investing.com Nigeria
What makes ZimVie Inc. stock price move sharplyAI Forecast for Trending Stocks Indicates Upside - beatles.ru
ZimVie Inc. Reports Q2 2025 Results Amid Acquisition - TipRanks
ZimVie Tops Estimates But Preps For ARCHIMED Buyout - Finimize
ZimVie earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Using RSI to spot recovery in ZimVie Inc.AI Powered High Return Stock Calls Dominate Watchlists - metal.it
ZimVie Reports Second Quarter 2025 Financial Results - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
ZimVie Inc. Forms Bullish Flag — Upside AheadLow Risk Equity Screener With Results Shared - metal.it
ZimVie’s Discounted Stock Draws Buyout Bids And Investor Caution - Finimize
ZimVie Inc. Sees Relief Buying After Extended DropReversal Alert Based on RSI Indicator Confirmed - metal.it
Published on: 2025-07-29 00:19:04 - metal.it
What institutions are buying ZimVie Inc. stock nowFast Gaining Stock Screener Reports Released - beatles.ru
What catalysts could drive ZimVie Inc. stock higher in 2025Capitalize on proven trading setups - jammulinksnews.com
What are the technical indicators suggesting about ZimVie Inc.Free Stock Market Forecast Reports - jammulinksnews.com
What are the latest earnings results for ZimVie Inc.Free Trend-Following Techniques - jammulinksnews.com
Is ZimVie Inc. a growth stock or a value stockFree Investment Case Studies - jammulinksnews.com
What is ZimVie Inc. company’s growth strategyBuild wealth faster with consistent growth stocks - jammulinksnews.com
What institutional investors are buying ZimVie Inc. stockGain access to exclusive stock analysis - jammulinksnews.com
What are analysts’ price targets for ZimVie Inc. in the next 12 monthsFree Risk Assessment Services - jammulinksnews.com
Is ZimVie Inc. Stock a Smart Buy in 2025 Investment Analysis InsideRisk Adjusted Stock Signals - metal.it
ZimVie to Announce Q2 Results July 30 - Dentistry Today
ZimVie withdraws guidance amid ARCHIMED transaction - TipRanks
ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025 - The Manila Times
ZimVie Sets Final Public Earnings Date Before $19/Share ARCHIMED Takeover - Stock Titan
Hold Rating Maintained on ZimVie Inc Amid Acquisition by ARCHIMED - TipRanks
What drives ZimVie Inc. stock priceGame-changing returns - Autocar Professional
ZIMV Expands Reach in China Through Osstem Implant Partnership | - GuruFocus
ZimVie inks exclusive dental implant distro deal with Osstem in China - MassDevice
ZimVie Doubles — And Then Some — On Its Second Takeover Deal - MSN
ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China - The Manila Times
ZimVie partners with Osstem Implant to expand in Chinese dental market - Investing.com
ZimVie partners with Osstem Implant to expand in Chinese dental market By Investing.com - Investing.com South Africa
ZimVie Inc. Enters Strategic Distribution Agreement with Osstem Implant to Expand Presence in China’s Dental Implant Market - Nasdaq
ZimVie Pioneers the Future of Molar Restoration with New Immediate Molar Dental Implant System - sg.finance.yahoo.com
ZimVie Targets Massive 10M Unit Chinese Dental Market Through Exclusive Osstem Partnership - Stock Titan
ZimVie to be acquired by Archimed for $19.00 per share in cash - MSN
ZimVie Inc. Stock Analysis and ForecastUnmatched market performance - jammulinksnews.com
Is ZimVie Inc. a good long term investmentFree Popular Stock Recommendations - jammulinksnews.com
ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc.ZIMV - The Globe and Mail
User - FinancialContent
Private Equity Firm Archimed To Buy ZimVie As Antitrust Concerns Sideline Strategic Buyers - insights.citeline.com
ARCHIMED To Buy ZimVie In $730 Million Deal - Pulse 2.0
ZimVie upgraded to Equal Weight from Underweight at Barclays - TipRanks
ZimVie to sell to investment firm for about $730M - MedTech Dive
Barclays upgrades ZimVie stock rating to Equalweight on Archimed merger By Investing.com - Investing.com Nigeria
Barclays upgrades ZimVie stock rating to Equalweight on Archimed merger - Investing.com Australia
What analysts say about ZimVie Inc. stockHigh-yield portfolio picks - jammulinksnews.com
Dental Implants and Prosthetics Market is projected to reach US$ - openPR.com
Zimvie Inc Stock (ZIMV) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):